Introduction
Today there is a great and urgent need to discover new antiparasitic compounds with different chemical structures and mechanisms of action because of the increase in the incidence of some parasitic diseases and the appearance of re-emerging parasitosis. In addition, drugs for the treatment of some parasitic diseases are scarce and sometimes non existent. Leishmaniasis and Chagas´ disease are two major parasitic diseases that cause signifi cant morbidity and mortality, and their treatment is still problematic.
Natural products have become a key source of new drugs in the last years (Fournet and Muñoz, 2002; Newman and Cragg, 2007) . The Euphorbia genus includes a wide and diverse group of plants which are characterized by the presence of an irritant latex rich in euphol and euphorbol triterpenes (Singla and Pathak, 1990) . This genus has been the subject of abundant phytochemical and pharmacological research because of its potential medical applications. Extracts of numerous Euphorbia species have been found to demonstrate a number of interesting biological activities against pathologies, such as swelling and warts, or anticancer properties (Fatope et al., 1996) . Furthermore, Euphorbia offi cinarum is used in traditional medicine to treat skin and ophthalmologic diseases (Daoubi et al., 2007) . A number of biologically active natural compounds have been isolated from this genus: euphol and euphorbol triterpenes have been reported as antiinfl ammatory and antiviral compounds which affect Xenopus cell division and human breast cancer cell viability (Yasukawa et al., 2000; Akihisa et al., 2002; Wang et al., 2003) . Other phorbol and ingenol derivatives have a potent antiproliferative activity in tumour cells (Irie et al., 2002; Kedei et al., 2004 The in vitro activity on Leishmania infantum promastigotes and Trypanosoma cruzi epimastigotes of 25 semisynthetic terpenoid derivatives has been evaluated. These compounds were obtained through chemical modifi cations of the major components of Euphorbia resinifera (α-euphol and α-euphorbol) and Euphorbia offi cinarum (obtusifoliol and 31-norlanosterol). Leishmaniasis and Chagas´ disease are major worldwide health problems. The drugs of choice for their treatment are still problematic in both cases, and therefore there is an urgent need to discover new drugs with high activity and low side effects. Natural products have become a key source of new drugs in the last years. The genus Euphorbia has been the subject of abundant phytochemical and pharmacological research because of its potential medical applications, but the antiparasitic effects of derivatives from plants of this genus are still unknown. Our results showed that 76% and 64% of the test compounds had antiparasitic effects on L. infantum and T. cruzi, respectively. The different activities on both parasites, especially their moderate effects on mammalian cells, indicate an interesting selective toxicity.
cauducifolia have proven molluscicidal activity (Baloch et al., 2009) , and several diterpenes from Euphorbia kansui have shown insecticidal (Shi et al., 2008a) and antinematodal activity (Shi et al., 2008b) . However, there are hardly any studies on the effects of Euphorbia derivatives on parasites and protozoa (Duarte et al., 2008) , and therefore their potential antiparasitic and antiprotozoal activities remain unknown.
Trypanosoma cruzi is the aethiologic agent of Chagas´ disease, a public health problem in many Latin American countries, including Europe due to the immigration from several countries of South America (Florián-Sanz et al., 2005; Muñoz et al., 2007; Gascon et al., 2010) . The treatment of Chagas´ disease is a challenge, since the only available drugs, such as nifurtimox and benznidazole, possess severe side effects. Moreover, their lack of effi ciency has involved problems in their production and distribution (Muelas-Serrano et al., 2000; Sra et al., 2004) . Leishmaniasis is a protozoan parasitic disease endemic in 88 countries, which causes considerable morbidity and mortality. The drugs most commonly used to treat leishmaniasis are pentavalent antimonials which require high dose regimens with extended treatments with compounds such as amphotericin B, paromomycin or pentamidine. However, all these drugs are far from being satisfactory due to unacceptable side effects at effective doses. Therefore, the search for new compounds to improve the actual treatments of Chagas´ disease and leishmaniasis is urgently needed (Dejeux, 2001; Croft and Coombs, 2003; Croft et al., 2005; Davis and Kedzierski, 2005; Murray et al., 2005) .
In this work, the in vitro activities on Leishmania infantum promastigotes and Trypanosoma cruzi epimastigotes of 25 semisynthetic terpenoid derivatives obtained by means of chemical modifi cations of the major compounds of E. resinifera and E. offi cinarum have been evaluated. Additionally, the selective cytotoxicity of these compounds on mammalian CHO cells has been tested.
Material and Methods

Plant material and chemical procedures
Latex from E. resinifera and E. offi cinarum were collected in the area of Dennat and Agadir (Morocco), and the procedures for extraction, isolation, and synthesis for obtaining the triterpene derivatives were performed as previously described (Mazoir et al., 2008 ). The list of tested compounds is shown in Table I . Obtusifoliol and 31-norlanosterol were obtained from E. offi cinarum; α-euphol and α-euphorbol were obtained from E. resinifera. The chemical structures of these compounds and their derivatives are shown in Figs. 1 and 2.
Antileishmanial screening
Leishmanicidal activity was assayed on promastigote forms of L. infantum, strain PB75, cultured at 28 °C in RPMI medium supplemented with 10% foetal calf serum. Parasites in the logarithmic growth phase were distributed in 96-well fl atbottom plates. The compounds to be tested were dissolved in DMSO (< 0.2% in order to avoid the toxicity of the solvent on the protozoa) and the resulting solution added to the cultures at several concentrations (at fi rst 100, 10, and 1 μg/ml; after, when some activity was detected, intermediate doses were evaluated) for 72 h. Amphotericin B was used as reference drug, and parasite viability was analysed by a modifi ed MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric assay (González-Coloma et al., 2002) . The activity was calculated as percentage of growth inhibition.
Trypanocidal activity
This activity was assayed on epimastigote forms of T. cruzi, strain Y, cultured in LIT medium. Parasites in the logarithmic growth phase (from an initial culture with 2 · 10 6 epimastigotes/ml) were distributed in 96-well fl at-bottom plates. Each well was treated with increasing concentrations of the compounds (as in leishmanicidal assays) for 96 h. Nifurtimox was used as reference drug, and parasite viability was analysed by a modifi ed MTT colorimetric assay (Muelas-Serrano et al., 2000) . All assays were carried out in triplicate, and the activity was calculated as percentage of growth inhibition.
Cytotoxicity assays
Mammalian Chinese hamster ovary cells (CHO) were used for these assays. The non-selective cytotoxicity of the test compounds was evaluated as described previously (Mazoir et al., 2008) .
In all cases, once active concentrations are known, intermediate doses were tested and ED 50 values (the effective dose to give 50% cell viability) were determined from linear regression analysis (% cell viability on log dose).
Results and Discussion
The leishmanicidal and trypanocidal activities of the compounds (Figs. 1 and 2) as well as the cytotoxicity on CHO cells are shown in Table II . Our results showed that 72% and 36% of the test compounds had important antiparasitic effects (ED 50 < 10 μg/ml) on L. infantum and T. cruzi, respectively. In contrast, mammalian CHO cells were affected (ED 50 < 50 μg/ml) by a lower number of compounds (44%), with some of them (28%) being selective parasite toxicants.
The strongest leishmanicidal compounds were 9 and 22 (ED 50 < 3 μg/ml) followed by 19, 21 (ED 50 < 4 μg/ml) > 5, 20, 24, 25 (ED 50 < 6 μg/ ml) > 6, 12 (ED 50 < 8 μg/ml) > 7, 8, 15, 16, 17, 18, 23 (ED 50 < 10 μg/ml), and 10 (ED 50 < 15 μg/ml).
Overall T. cruzi was less sensitive to these compounds, with 21 and 22 (ED 50 < 5 μg/ml) being the most active, followed by 6, 8, 20 (ED 50 < 7 μg/ml) > 9, 15, 23, and 25 (ED 50 < 10 μg/ml). Therefore 5, 7, 10, 12, 16, 17, 18, 19, and 24 were selective leishmanicidal terpenes (11 -2 times more potent). Compound 23 was the most cytotoxic to CHO cells. The rest of cytotoxic compounds had moderate effects. Therefore, all strong antiparasitic compounds had low to moderate cytotoxicity.
Comparing the antiparasitic activity of the products and their toxicity on mammalian CHO cells (considering it as a control for nonspecifi c cytotoxicity), we can see that 5, 7, 10, and 12 showed signifi cant selective leishmanicidal activity with a low or moderate nonspecifi c cytotoxicity. In addition, 8, 20, and 22 showed signifi cant activity against both parasites (L. infantum and T. cruzi) without nonspecifi c cytotoxicity associated. Among them, 5 and 10 stood out as strong selective leishmanicidal products without associated toxicity, 20 and 22 as strong leishmanicidal and trypanocidal products without associated toxicity. Overall, among the tetracyclic triterpenes, the most active compounds were highly oxygenated with ketone/OH substituents at C-3 and C-7 and/ or C-11 and/or the presence of a substituent at C-24 (epoxy or ketone group) in the lateral chain.
The presence of a hydroxy group at C-3 determined the activity of the lupeol derivative 12.
A number of terpenes with antileishmanial and antitrypanosomal activity have been reported but their modes of action are not clear. Different au- thors suggested that they can be related with the inhibition of the synthesis of proteins and nucleic acids or with the inhibition of a membrane-associated calcium-dependent ATPase pump (Goijman et al., 1984; Mishina et al., 2007) . T. cruzi and Leishmania parasites have a strict requirement for specifi c endogenous sterols (ergosterol and analogues) for survival and growth (Urbina et al., In conclusion, the triterpenes tested showed high activity against both parasites, particularly Leishmania. However, the different activities on both parasites, and especially their moderate effects on mammalian cells, indicate an interesting selective toxicity. These preliminary positive results suggest further work with these compounds (especially 5, 10, 20, and 22) in order to discover new drugs with high activity and low side effects against diseases caused by protozoan parasites, such as leishmaniasis and Chagas´ disease. 
